Trademark Search  /  STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS

STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS

○ Dead · Abandoned

U.S. federal trademark · Serial No. 77802485

Mark
STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
Status
Abandoned
Serial Number
77802485
Filing Date
August 12, 2009
Class(es)
Class 042

Owners

Bristol-Myers Squibb Company
03 · New York, NY, US
Bristol-Myers Squibb Company
03 · New York, NY, US

Goods & Services

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.